ConductScience.org, home

Paper16650970

Characterisation of the onset and presenting clinical features of adult bronchiectasis.

King PT and 4 others. Respir Med, 2006. Cited by 183 papers, by iCite.

Cite this record

ConductScience Library. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Papers, record 16650970. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16650970

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characterisation of the onset and presenting clinical features of adult bronchiectasis.
PubMed
Journal
Respir Med
PubMed
Year
2006
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
183
iCite
Relative citation ratio, by iCite
5.64
iCite
Revised in PubMed
2022-04-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1King PTPaul T
2Holdsworth SRStephen R
3Freezer NJNicholas J
4Villanueva EElmer
5Holmes PWPeter W

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BronchiectasisMajor topic
Asthma
Chronic Disease
Cohort Studies
Cough
Cross-Sectional Studies
Dyspnea
Fatigue
Female
Humans
IgG Deficiency
Male
Middle Aged
Pneumonia
Pulmonary Disease, Chronic Obstructive
Respiratory Function Tests
Respiratory Sounds
Rhinitis
Sinusitis
Smoking
Sputum

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT05719597PEP Breathing Versus Incentive Spirometry on Dyspnea and Sputum Profile in Bronchiolectasis PatientsBackgroundClinicalTrials.gov
NCT06209047Bronchoscopic Levofloxacin, Gentamicin, or Sham for Acute Exacerbation of BronchiectasisResultsClinicalTrials.gov

Download CSV of trials

Cited by81

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 183 citations.

PMIDTitleJournalYearIn PapersSource
42155584Active Cycle of Breathing Technique Versus Oscillating Positive Expiratory Pressure Therapy Versus Exercise With Huffing During an Exacerbation of Bronchiectasis: A Randomised, Controlled Trial.Respirology2026https://conductscience.org/library/papers/42155584PubMed
42094231Validation of bronchial airway gene expression associated with bronchiectasis in nasal epithelium.ERJ Open Res2026https://conductscience.org/library/papers/42094231PubMed
41881528Study protocol for testing a mobile app designed to improve health literacy and self-management in people with bronchiectasis: the ANIMA app.BMJ Open2026https://conductscience.org/library/papers/41881528PubMed
41555409
Effects of atorvastatin on inflammatory markers, lipid profile, liver enzymes, and pulmonary function in patients with lung diseases: a systematic review and meta-analysis of randomized controlled trials.
Eur J Med Res2026https://conductscience.org/library/papers/41555409PubMed
41535950Integrated traditional Chinese medicine and Western medicine strategies for the treatment of bronchiectasis: a comprehensive review.Chin Med2026https://conductscience.org/library/papers/41535950PubMed
41474423Evaluating serum TNF α in relation to bronchiectasis severity: Insights from FACED and BSI scoring systems.Lung India2026https://conductscience.org/library/papers/41474423PubMed
40512220Respiratory symptoms associated with a new lobe-based bronchial scoring system in an urban Chinese low-dose CT screening population.Eur Radiol2025https://conductscience.org/library/papers/40512220PubMed
40040890Heart rate recovery after the 6-min walk test in people with bronchiectasis.ERJ Open Res2025https://conductscience.org/library/papers/40040890PubMed
40001409Utilization of Inhaled Antibiotics in Pediatric Non-Cystic Fibrosis Bronchiectasis: A Comprehensive Review.Antibiotics (Basel)2025https://conductscience.org/library/papers/40001409PubMed
39478731Characteristics of different pathogenic bacterial infections and their effects on prognosis in adult patients with bronchiectasis.Exp Ther Med2024https://conductscience.org/library/papers/39478731PubMed
39386750A comprehensive review of Mycoplasma pneumoniae infection in chronic lung diseases: recent advances in understanding asthma, COPD, and bronchiectasis.Front Med (Lausanne)2024https://conductscience.org/library/papers/39386750PubMed
39145140Clinical Predictors of Nontuberculous Mycobacteria Lung Disease and Coisolates of Potential Pathogenic Microorganisms in Noncystic Fibrosis Bronchiectasis.Open Forum Infect Dis2024https://conductscience.org/library/papers/39145140PubMed
39070447A Case of New-Onset Atrial Tachyarrhythmias With Apical Hypertrophic Cardiomyopathy and Bronchiectasis in a Very Elderly Patient: A Therapeutic Dilemma.Cureus2024https://conductscience.org/library/papers/39070447PubMed
38978557Nontuberculous mycobacterial pulmonary disease added burden to COPD and bronchiectasis in Japan.ERJ Open Res2024https://conductscience.org/library/papers/38978557PubMed
38921790Medical Causes of Hospitalisation among Patients with Bronchiectasis: A Nationwide Study in Japan.Pathogens2024https://conductscience.org/library/papers/38921790PubMed
38628883Effects of Probiotics on Clinical Manifestations of Bronchiectasis: A Randomized, Triple Blinded, Placebo-Controlled Clinical Trial.Tanaffos2023https://conductscience.org/library/papers/38628883PubMed
38499811Asymptomatic Dysphagia and Aspiration in Patients with Idiopathic Bronchiectasis.Lung2024https://conductscience.org/library/papers/38499811PubMed
38422338Clinical determinants of the modified incremental step test in adults with non-cystic fibrosis bronchiectasis.J Bras Pneumol2024https://conductscience.org/library/papers/38422338PubMed
38390464Cystic Fibrosis Carrier States Are Associated With More Severe Cases of Bronchiectasis.Open Forum Infect Dis2024https://conductscience.org/library/papers/38390464PubMed
37969279Cough in chronic lung disease: a state of the art review.J Thorac Dis2023https://conductscience.org/library/papers/37969279PubMed

See all 81 cited byDownload CSV of cited by

Drugs3

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
BUDESONIDECHEMBL1370Results1https://conductscience.org/library/drugs/CHEMBL1370ChEMBL
LEVOFLOXACINCHEMBL5315124Results1https://conductscience.org/library/drugs/CHEMBL5315124ChEMBL
GENTAMICINCHEMBL6067485Results1https://conductscience.org/library/drugs/CHEMBL6067485ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16650970

GET https://conductscience.org/api/papers/v1/16650970/cited_by?page=2